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Three related proteins of the plakophilin family (PKP1 3) have been identiﬁed as junctional proteins that are essential for
the formation and stabilization of desmosomal cell contacts. Failure of PKP expression can have fatal eﬀects on desmosomal
adhesion, leading to abnormal tissue and organ development. Thus, loss of functional PKP 1 in humans leads to ectodermal
dysplasia/skin fragility (EDSF) syndrome, a genodermatosis with severe blistering of the epidermis as well as abnormal
keratinocytes diﬀerentiation. Mutations in the human PKP 2 gene have been linked to severe heart abnormalities that lead to
arrhythmogenic right ventricular cardiomyopathy (ARVC). In the past few years it has been shown that junctional adhesion is not
the only function of PKPs. These proteins have been implicated in cell signaling, organization of the cytoskeleton, and control of
protein biosynthesis under speciﬁc cellular circumstances. Clearly, PKPs are more than just cell adhesion proteins. In this paper
we will give an overview of our current knowledge on the very distinct roles of plakophilins in the cell.
1.Introduction
Cellular adhesion is mediated by distinct protein complexes
at the cytoplasmic membrane, termed junctions, that have
been characterized by their morphology on the ultrastruc-
tural level [1]. Desmosomes reveal a characteristic appear-
ance and anchor diﬀerent types of intermediate ﬁlaments
(IF) to the cell membrane. The fundamental functional
importance of desmosomal cell contacts for cellular and
tissue architecture, diﬀerentiation, development, and tissue
stability is generally accepted and has previously been
described [2–4]. Experimental evidence for the importance
of desmosomal adhesion for speciﬁc tissues and organs has
been established by knockout experiments of desmosomal
genes in mice (see, e.g., [5]). Moreover, examination of
a variety of human diseases characterized by a loss, or
impairment of desmosomal adhesion—regardless of genet-
ical, autoimmune, or infectious etiology—advanced our
understanding of desmosomal function [6]. Desmosomes
are formed by all epithelial tissues and tumors derived there-
from as well as by speciﬁc nonepithelial tissues such as heart
muscle cells. Desmosomal cadherins (i.e., desmogleins DSGs
and desmocollins DSCs) located on adjacent cells mediate
intercellular connection via interactions of their extracellular
domains (for review see [7]). On the cytoplasmic side of
the plasma membrane, IF are linked to the desmosomal
cadherins via desmosomal plaque proteins. Besides the con-
stitutive desmosomal plaque proteins desmoplakin (DSP)
and plakoglobin (JUP), at least one of the three classical
members of the plakophilin family (PKP 1 to PKP 3) is
required for the formation of functional desmosomes [8–
10] .Th er o l eo fP K P si nc ell u l a rad h e s i o nh a v ebee na n a l y z ed
in detail during the past decade [8–10]. However, additional
functions of the plakophilins that are not directly linked to
desmosomal adhesion have recently been described. In this
review we want to provide insights not only into the known
properties and functions of plakophilins in desmosomes, but
also into cellular functions not related to adhesion.
2. Common Features of the Plakophilins
Plakophilins are probably the most basic proteins identiﬁed
incellularadhesioncomplexessofarwithanisoelectricpoint2 Dermatology Research and Practice
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Figure 1: Immunohistochemical staining of sections of human skin with antibodies against PKP 1. Sections of formaldehyde-ﬁxed tissue
samples of human skin were stained with a monoclonal antibody (clone PP1 5C2; Progen, Heidelberg; for methods see [18]) against PKP 1
a to d. (a) Overview of epidermis showing a strong reaction of the antibodies at the desmosomes of all layers. (b) At a higher magniﬁcation,
the basal layers exhibit a somewhat weaker desmosomal staining that can be resolved occasionally into individual spot-like desmosomes
containing PKP 1. During keratinocyte diﬀerentiation, desmosomal labeling is getting more pronounced. (c) Cross-section of a hair follicle
(Hf) with desmosomal staining of the outer root sheath while the hair-shaft is not stained (Sg, sebaceous gland). Arrow marks the duct of a
sebaceous gland. (d) Eccrine sweat ducts are marked intensively by antibodies while the secretory portions of eccrine glands show a distinct
but weaker staining (arrow). Apocrine sweat glands (lower left corner) are negative. Scale bars: 100μm (b); 200μma ,c ,a n dd .
(pI)ofaboutpH9.3.Basedontheirprimarysequences,PKPs
have been classiﬁed as a distinct subfamily of the armadillo
repeat proteins (for review see [11]). The carboxyl-terminal
part of the proteins includes nine armadillo repeats which
contain a spacer sequence between the ﬁfth and sixth repeat
that leads to a characteristic kink in the domain structure as
determined by crystallography of the armadillo domain of
PKP 1 [12]. The amino-terminal parts (head domain) of the
three plakophilins are rather diverse and exhibit no obvious
homology to themselves or other proteins. Only a small
sequence near the amino-terminus, designated homology
region (HR) 2, shows some degree of homology between the
plakophilins. An analysis of amino acid sequence homology
revealsthatthePKPsarerelated tothecateninproteins ofthe
p120ctn-group, which are associated with classical cadherins,
such as E-cadherin, in adherens junctions. The PKPs are
more distantly related to the classical catenins, β-catenin and
plakoglobin [8, 13]. PKPs show complex but overlapping
expression patterns in mammalian tissues. Certain cells and
tissues express only one type of PKP. Mutations aﬀecting the
corresponding PKPs thus can lead to severe diseases in these
tissues since compensatory PKP isoforms are not expressed
ormaynotsubstituteforallfunctionalaspects.Thisprobably
explains the severe skin diseases caused by PKP 1 mutations
and the heart diseases caused by PKP 2 mutations.
2.1. Plakophilin 1. PKP 1 is the smallest of the plakophilins,
with a calculated molecular weight of 80.497Da and an
apparent molecular weight of approximately 75kDa as
judged by SDS-PAGE [14]. This protein is localized in the
desmosomesofstratiﬁed,complex,andtransitionalepithelia
but is absent in simple epithelia [14–16]. In stratiﬁed
epithelia, PKP 1 is synthesized in all cell layers, with an
increase in expression from the basal to the granular com-
partment as determined by quantiﬁcations of PKP 1-speciﬁc
immunoﬂuorescence signal intensity in human epidermis
[17]. This indicates that PKP1 is a marker for keratinocyte
diﬀerentiation. PKP 1 appears to be absent in the stratum
corneum of stratiﬁed squamous epithelia though (Figure 1).
The human PKP 1 gene is expressed as two diﬀerent
splice variants which diﬀer with respect to cell-biological
behavior, molecular weight, and abundance. PKP1a is the
smaller isoform while the larger PKP1b isoform (predicted
molecular weight: 82.860kDa) is less abundant in stratiﬁed
epithelia. The additional amino acid sequence contained
in PKP1b is encoded by exon 7 which is spliced out of
the PKP1a mRNA [19]. The PKP1b-speciﬁc amino acid
sequence is located at the end of the fourth armadillo repeat
and has a distinct eﬀect on the cell biological activities
of the protein. In addition to its desmosomal localization,
PKP 1 has been detected in the nucleus of a broad rangeDermatology Research and Practice 3
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Figure 2:PositionofmutationsinhumanPKP1gene.SchematicrepresentationoftheproteinstructureofPKP1withheaddomain“Head”
inbluecolorcontainingthehomologousregion2“HR2”neartheamino-terminuswhichisfollowedbyninearmadillorepeats(yellowboxes;
numbered in circles from 1 to 9). Finally, a short domain (blue) at the carboxyl-terminus is shown. Positions of homozygous mutations are
marked by double arrows, positions of compound heterozygous mutations by connected arrows. Green arrows designate mutations aﬀecting
the coding region, red arrows denote splice-site mutations. For numbering and references of the mutations see Table 1.
of cell types, even in those that do not incorporate PKP
1 in desmosomes such as simple epithelial cells [14, 19].
This distinct subcellular distribution has been observed for
both variants of PKP 1. While the smaller PKP 1a may
also be present in desmosomes, PKP 1b localization is
restricted to the nucleus and not detectable in desmosomes.
This conclusion is supported by transfection of cDNAs into
cultured cells, where PKP 1a accumulates in desmosomes
and is also rapidly transferred into the nucleus, while PKP
1b is only nuclear (own observations). Nevertheless, neither
the way PKP 1 enters the nucleus nor the functions of this
protein therein are yet known.
Both the nuclear and desmosomal PKP 1 pool are
degraded by caspases rapidly during apoptosis of ker-
atinocytes suggesting that this protein is involved in the
remodeling of the cytoskeleton under these conditions [20].
Signalingfunctions,asshownforsomeoftherelatedcatenins
such as β-catenin, plakoglobin, and p120ctn,h a v eb e e n
postulated for PKP 1, but proof is still lacking [21, 22]. A
typical nuclear localization signal has not been identiﬁed
in the protein so far, but cDNA transfection studies of the
complete protein or individual parts of the protein into cells
have shown that the head domain on its own, and to some
extent the armadillo domain, are able to enter the nucleus
[23]. The mechanism of the PKP 1 nuclear migration is
currentlyunknown,butmayutilizeapiggybackmechanism.
Various in vitro approaches revealed that the binding
of desmosomal PKP 1 to other desmosomal proteins such
as DSP, DSG 1, DSC 1, and diﬀerent keratins is mediated
by its head domain sequence [24–28]. The armadillo repeat
domain of PKP 1 alone is suﬃcient to localize the protein
to the plasma membrane [23]. The PKP 1 binding partner
at the plasma membrane has not been determined but
might be one of the desmosomal proteins or even cortical
actin. In particular, it has been observed that the armadillo
domain coaligns with actin microﬁlaments under certain
circumstances and may be involved in the reorganization of
thiscytoskeletalcomponent[26].Nevertheless,thecarboxyl-
terminal part, in particular the last 40 amino acids, seems
to be essential for the recruitment of the entire PKP 1
to the plasma membrane as shown by transfection stud-
ies of mutant cDNA constructs into A431 keratinocytes
[28].
Important clues for the understanding of PKP 1 function
came from a report of an autosomal-recessive genodermato-
sis that is caused by mutations in the PKP 1 gene [29].
The ectodermal dysplasia/skin fragility (EDSF) syndrome
(OMIM 604536; the collection of known mutations in the
PKP 1 gene is shown in Figure 2 and published cases of
EDSF syndrome are listed in Table 1) clinically manifests in
the skin and its appendages. Patients suﬀer from blistering
with erosions of their skin upon mechanical stress. Nails are
dystrophic and the epidermis of soles and palms displays
hyperkeratosis. The hair density on the scalp, eyebrows, and
eyelashesisreduced.Inseverecases,hairmightbecompletely
absent from these body regions. Impaired sweating has
occasionally been observed. All other epithelial tissues that
express PKP 1, including mucous membranes, seem to be
normal in these patients, suggesting functional compensa-
tion by the other PKPs. Histological examination of aﬀected
skin reveals that the intercellular space is widened and
epidermalkeratinocytesareacantholyticfromthesuprabasal
layers upwards, suggesting loss of cell-cell adhesion. Cell
rupture, as noticed for epidermolytical bullous dermatosis,
has not been observed. Immunoﬂuorescence microscopy
analysesofpatients’skinbiopsiesshowedthatcertaindesmo-
somal components such as desmogleins, desmocollins, and
plakoglobin are still localized at the plasma membrane. In
contrast, PKP 1 is completely absent or drastically reduced
[30]. As a consequence, desmoplakin is no longer localized
in the desmosomes but instead is dispersed throughout
the cytoplasm. On the ultrastructural level, desmosomes
appear smaller and are numerically reduced in the aﬀected
epidermal layers. Additionally, keratin ﬁlaments have lost
contact to desmosomal junctions and are collapsed around
the nucleus. Biochemical analysis of patients’ skin revealed
that the other PKPs are upregulated to some extent and may
compensate in part for the loss of PKP 1 in nonaﬀected
epidermal layers [17]. Interestingly, it does not seem to mat-
ter for the development of the clinicopathological ﬁndings
of EDSF syndrome to what extent the protein is truncated
due to the mutations in PKP 1 gene. In a case reported by
McGrath and colleagues the mutations occurred close to the
amino-terminus of the protein, which could result either in
a severely truncated protein or—more likely—in complete
loss of the protein (i.e., a functional null mutation) as4 Dermatology Research and Practice
Table 1: Published cases of EDSF syndrome with clinical features and observed mutations in PKP 1 gene.
Case1 Clinicopathological ﬁndings Observed
mutations2 Reference
Epidermal fragility Hyperkeratosis
on palms/soles
Alopecia Nail dysplasia Hypohidrosis
1 yes yes yes yes yes (a) p.Q304X (b)
c.1132ins28
[29]
2 yes yes yes yes yes (a) p.Y71X (b)
IVS1−1G>A
[31]
3 yes yes yes yes no IVS6−2A>T [32]
4 yes yes yes yes yes IVS11+1G>A [30]
5 yes no yes yes no IVS4−2A>G [33]
6 yes yes yes yes not observed IVS1−1G>A [33]
7 yes yes no yes no IVS9+1G>A [34]
8 yes yes yes yes no
(a) c.1053T>A
+IVS5+1G>A( b )
IVS10−2G>T
[35]
9 yes yes yes yes no c.888delC [36]
10 yes yes yes yes not observed p.R672X [37]
1Numbering of the case correlates to the positions of mutations shown in Figure 2.
2 For compound heterozygosity, mutations of both alleles are given as (a) and (b).
judgedbyimmunoﬂuorescencemicroscopy[29].Incontrast,
the mutations in the PKP 1 gene reported by Hamada
et al. occurred near the carboxyl-terminus resulting in
the expression of a truncated protein. Based on the mild
phenotype of the ESDF syndrome in these patients, it can
be assumed that this truncated protein is at least partially
functional but clinicopathology of ESDF still manifests [30].
Surprisingly, most of the EDSF-related mutations in human
PKP 1 gene involve splice-site mutations (8 out of 13
knownmutatedalleles)leadingtoimpairedsplicingproducts
and subsequent mRNA degradation or the generation of
truncated proteins. The reason for the prevalence of splice-
site mutations in EDSF is not known.
These ﬁndings in conjunction with cell biological data
obtained in transfection studies convincingly illustrate that
PKP 1 is essential for the recruitment of desmoplakin to
the desmosomal plaque and probably is involved into lateral
enlargement of the plaque structure in skin, explaining the
structural and functional defects in epidermal desmosomes
lacking PKP 1. Evidently, integration of PKP 1 in the
desmosomes provides the epidermal keratinocytes with
stability against mechanical stress. A sequence stretch in the
HR2 domain of PKP 1 is thought to be essential for the
r e c r u i t m e n to fD S Pa n dr e p r e s e n t sac o n s e r v e dm o t i fo fa l l
the PKPs, suggesting that DSP recruitment is a common
function of all PKPs [28].
Although a direct interaction of PKP 1 with keratins
has been demonstrated frequently in vitro, it is not clear
whether this protein alone is suﬃcient to connect the inter-
mediate ﬁlament cytoskeleton to the desmosome. Speciﬁc
inactivation of DSP in the skin of mice demonstrates the
necessity of both proteins, DSP and PKP 1 (in cooperation
with plakoglobin), for anchorage of keratins [38] suggesting
that all three components are required. This is further
demonstrated by the fact that failure of either PKP 1 or
DSP can lead to loss of cell-cell adhesion and acantholysis
in the epidermis. The mechanism underlying the failure of
epidermal desmosomes without PKP 1 to maintain adhesion
is not known. It is tempting to speculate that besides struc-
tural defects cell signaling defects could contribute to this
phenomenon, similar to the disease mechanisms postulated
for the autoimmune blistering diseases of the pemphigus
groupinwhichautoantibodiestargetdesmosomalcadherins.
Binding of autoantibodies to the desmosomal cadherins
seems to trigger intracellular signaling pathways that lead to
the reorganization of the cytoskeleton involving the discon-
nection of desmosomal cadherins of adjacent cells (for the
mechanisms of this outside-in signaling see [39]). The same
pathways may be involved in the dissolution of desmosomal
adhesion when PKP 1 is lost. Given that patients with PKP
1 null mutations show defects in diﬀerentiation pathways
aﬀecting skin appendage formation and homeostasis, it is
unlikely that adhesion defects can account for the entire
spectrum of disease phenotypes.
Analysis of keratinocytes derived from patients suﬀering
from EDSF syndrome exhibits some interesting properties.
Quantitative analyses of the desmosome size in cultured
cells revealed that reintroduction of PKP 1 increases the
lateral extent of desmosomes. As proposed by others [25,
40], desmosomal cohesiveness might be increased by lateral
interactions of PKP 1 with DSP, making additional linkage
between desmosomal proteins and keratin network accessi-
ble [41]. It is noteworthy that PKP 1 null keratinocytes show
increased cell migration, which has implications for tumor
biology.
2.2. Plakophilin 2. PKP 2 is, with a predicted mass of
92.756Da and an apparent molecular weight of 100kDa
(estimated from Western blot analysis), the largest of theDermatology Research and Practice 5
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Figure 3:Immunohistochemicalstainingofsectionsofhumanskina,andbandliverc,anddwithantibodiesagainstPKP2.(a)Thestaining
of samples of human skin with a monoclonal antibody against PKP 2 (clone PP2-150; Progen, Heidelberg) demonstrates a weak and delicate
desmosomal staining as well as cytoplasmic staining in the basal layer of the interfollicular epidermis (arrow). Suprabasal keratinocytes
remain unstained. (b) Eccrine sweat glands and ducts show a strong reaction with PKP 2-speciﬁc antibodies while apocrine sweat glands
exhibit an apical, distinct but weak desmosomal reaction (arrow). (c) Hepatocytes as well as bile ductules are marked at the cell-cell contacts
by PKP 2-speciﬁc antibodies (arrow). (d) Bile ducts also show a sharp and apical staining of desmosomal structure by the PKP 2-antibodies.
The samples shown in (c) and (d) are derived from liver tissue in the vicinity of a metastasis of a gastrointestinal stromal tumor with portal
and periportal ﬁbrosis and ductal and ductular proliferation. Scale bars: 100μm (d), 200μm( a ,b ,c ) .
three plakophilins and it is also the prevailing isoform since
it is expressed in all cell types with desmosomal junctions
[42]. PKP 2 is found in the basal cells of certain stratiﬁed
epithelia while more diﬀerentiated keratinocytes are negative
for desmosomal PKP 2 (Figure 3). Moreover, PKP 2 has
recently also been found in new types of cell junction which
diﬀer in terms of their biochemical composition from both
classical desmosomes and conventional adherens junctions
(reviewed in [43]). Similar to PKP 1, PKP 2 also occurs as
two diﬀerent splice variants. An additional exon coding for
44 amino acids is integrated into PKP 2b close to the border
of the second to third armadillo repeat of the protein [42].
The two PKP 2 splice variants appear to be coexpressed in
all cell types analyzed thus far, and it is not known whether
these two proteins have diﬀerent functions.
L i k eP K P1 ,P K P2h a sb e e nd e t e c t e di nt h en u c l e u so f
many cell types [42]. Its presence in the nucleus is inde-
pendent of its presence in desmosomes. Some nonepithelial
cell types, which do not assemble desmosomes, show only
nuclear localization of PKP 2 (e.g., ﬁbroblasts [42]). In strat-
iﬁed epithelia, nuclear and desmosomal localization of PKP2
is regulated independently. In the diﬀerentiated layers of
stratiﬁed epithelia, PKP 2 is excluded from desmosomes and
accumulates in the nuclei of keratinocytes. Recently, M¨ uller
andcolleaguesidentiﬁedamolecularpathwaythatappearsto
regulate nuclear accumulation of PKP 2 [44]. The Cdc25C-
associated kinase 1 (C-TAK 1) emerges to be involved in
cell-cycle regulation and Ras-signaling. It was shown that C-
TAK 1 phosphorylates Cdc25C and KSR1, a scaﬀold protein
for mitogen-activated protein kinase (MAPK) and Raf-1
kinase. M¨ uller et al. demonstrated that PKP 2 is also a
substrate for C-TAK 1 [44]. This phosphorylation of PKP 2
enforces an interaction of PKP 2 with 14-3-3 proteins, which
prevents the nuclear accumulation of PKP 2. Consequently,
mutation of the C-TAK 1 phosphorylation site or the 14-3-
3 binding domain in PKP 2 increases nuclear accumulation
of PKP 2. The pathways that trigger C-TAK 1-mediated
phosphorylation of PKP 2 and its retention in the cytoplasm
have not been analyzed so far.
What does PKP 2 do in the nucleus? Recent experiments
by Mertens and colleagues provided some insights [45].
Immunoprecipitation experiments revealed an association
of PKP 2 with the largest subunit of RNA-polymerase-III
holoenzyme, protein RPC155, as well as other components
such as RPC82 and RPC39. The PKP 2-positive complexes
also contain RNA-polymerase-III-associated transcription
factor TFIIIB but not TFIIIC. The colocalization of PKP 2
and RPC155 in particles in the interchromatin space has6 Dermatology Research and Practice
been shown by immunoﬂuorescence microscopy. Mertens
and colleagues [45] postulated that these particles do not
represent active forms of polymerase-III, because the PKP 2-
positive particles do not contain transcription factor TFIIIC,
af a c t o rr e q u i r e df o rt h ef o r m a t i o no fa na c t i v eR N A
polymerase III complex. Thus, the actual function of these
complexes remains unclear. Nevertheless, the almost general
appearance of PKP 2, as well as PKP 1, in the nucleus
seems to diﬀer fundamentally from the nuclear localization
of other related catenins such as β-catenin or p120ctn,w h i c h
are translocated into the nucleus upon speciﬁc signals and
have been shown to be involved in gene regulation [21, 22].
Besides these nuclear functions, PKP 2 may be involved
in cytoplasmic signaling, which is based on the observation
that it can bind β-catenin [46], a key downstream eﬀector
protein of the canonical Wnt-signaling pathway [21]. Using
two-hybrid and immunoprecipitation assay, it was shown
that PKP 2 can bind to β-catenin. However, when bound
to PKP 2, β-catenin cannot associate to E-cadherin, which
may reduce the pool of β-catenin available to function in cell
adhesion. Overexpression of PKP 2 in colon carcinoma cells
l e a d st oa ni n c r e a s ei nβ-catenin/TCF signaling suggesting a
regulatory role of PKP 2 in Wnt signaling and providing a
potential functional link between desmosomal adhesion and
signaling [46].
PKP 2 also seems to be involved in the assembly of
the desmosomal components into desmosomes. siRNA-
mediated depletion of PKP 2 in keratinocytes leads to
changes in the subcellular localization of DSP which mimics
the behavior of a DSP mutant deﬁcient for a PKCα (i.e.,
protein kinase C) phosphorylation site. Diﬀerent isoforms
of PKC have been implicated in the regulation of cellular
processessuchasmigration,cellularadhesion,orcytoskeletal
reorganization (for review see [47]). Bass-Zubeck et al.
investigated the connection between PKP 2, DSP, and PKC
[48]. The authors found that PKP 2 binds to PKCα and
DSP via its head domain. A detailed analysis revealed that
PKP2simultaneouslybindsDSPandPKCα,whichfacilitates
the subsequent phosphorylation of DSP at its IF-binding
domain by PKC [48]. This increases DSP integration into
the desmosomes and the subsequent attachment of IFs to
desmoplakin.
Insights into the function of PKP 2 also came from
gene knockout experiments in mice, as well as the analysis
of an autosomal-dominant human hereditary disease linked
to PKP 2 mutations [49, 50]. Ablation of the PKP 2
gene in mice leads to a lethal phenotype around mid-
gestation (E10.5) [49]. Homozygous PKP 2-null embryos
died because of severe alterations of the heart structure
resulting in the outﬂow of blood into the pericardium and
subsequent collapse of the embryonic blood circulation.
On the microscopic level, PKP 2 deﬁcient hearts display
reduced trabeculation as well as abnormally thin cardiac
walls. The reason for the instability of cell contacts between
cardiomyocytes is apparent on the ultrastructural level.
The junctional complexes of the areae compositae (formerly
designated as intercalated disks; see [43]) that connect
cardiomyocytes include at least two types of junctions in an
amalgamated fashion, desmosomes and adherens junctions.
The areae compositae are altered signiﬁcantly in PKP 2-
mutant mice. Associated with the deﬁciency of PKP 2, DSP
is depleted from the desmosomal junctions and accumulates
in the cytoplasm. Additionally, DSG 2 expression seems to
b er e d u c e di nP K P2 - n u l lc a r d i o m y o c y t e sa n dd e s m o s o m a l
components were less resistant to detergent extraction, sug-
gesting impaired function of cell junctions. Therefore, PKP 2
seems to be essential for the regular subcellular distribution
of desmoplakin and its accumulation in the areae compositae
of cardiomyocytes. Interestingly, Grossmann et al. found no
alteration in other PKP 2-expressing epithelia in the mutant
animals [49]. This is likely due to the expression of multiple
PKP isoforms in many cell types (except for the heart which
expressesonlyPKP2),providingfunctionalcompensationin
case one isoform is not functional.
The essential function of PKP 2 in the heart was also
demonstratedbytheidentiﬁcationofahaplo-insuﬃciencyof
PKP 2 in a hereditary human disease, autosomal-dominant
arrhythmogenic right ventricular cardiomyopathy (ARVC;
[50]).InARVC,cardiomyocytesareprogressivelyreplacedby
ﬁbro-fatty tissue, especially in the right ventricle (for a recent
review see [51]). This replacement leads to abnormal electri-
cal conductance with syncopes and tachycardia and an often
lethal failure in the mechanical capability of the heart (e.g.,
“sudden cardiac death” of young athletes). The mechanism
leading to ARVC may include apoptosis of cardiomyocytes
due to the weak and disrupted intercellular adhesion of
cardiomyocytes caused by haplo-insuﬃciency of PKP 2 and
subsequent insuﬃcient anchorage of DSP [52]. The decline
of cardiomyocytes may therefore lead to the development
of scar tissue in the right ventricle. Moreover, transdiﬀer-
entiation of cardiomyocytes into ﬁbro- or adipocytes may
take place, probably caused by disturbed Wnt/β-catenin-
signaling [53, 54]. This is supported by further observations.
The decrease of DSP in cultured atrial myocytes by siRNA
resultsintheredistributionofplakoglobintothenucleusand
the suppression of the canonical Wnt/β-catenin-signaling
pathway [54]. Genes inducing adipogenesis and ﬁbrogenesis
were upregulated in these DSP-deﬁcient cells. Decrease of
DSP was also noticed in cardiomyocytes of PKP 2-deﬁcient
mice [49], suggesting that a cellular transdiﬀerentiation
may also occur in ARVC. At least 12 diﬀerent genes or
chromosomal loci have been associated with the autosomal-
dominant or recessive types of ARVC so far, including all ﬁve
known desmosomal genes expressed in cardiomyocytes (i.e.,
DSG 2, DSC 2, DSP, JUP, and PKP 2).
The loss of PKP 2 may also contribute to the abnormal
electrical conductance of the heart [55]. Gap junctions play
an essential role in the electrical coupling of cardiomyocytes
and the coordinated heart contraction (reviewed in [56]).
Downregulation of PKP 2 in primary cardiomyocytes of
rat heart leads to reduced expression of the gap junction
protein connexin 42. In addition, a decrease of cellular
coupling via gap junctions is also detectable, which may
result in the disturbed transmission of electrical impulses in
the ventricle. Therefore, it appears that PKP 2 can inﬂuence
the organization of diﬀerent types of cellular junctions
such as gap junctions and areae compositae in heart muscle
cells.Dermatology Research and Practice 7
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Figure 4: Immunohistochemical staining of sections of human skin a, and b and liver c, and d with antibodies against PKP 3. (a) Intensive
reaction of desmosomes and cytoplasm is visible by staining sections of human skin with a monoclonal antibody against PKP 3 (clone PKP3
310.9.1; Progen, Heidelberg). Basal and lower suprabasal keratinocytes exhibit a strong cytoplasmic staining while desmosomal staining is
less prominent. With ongoing diﬀerentiation, the desmosomal labeling is increasing. (b) Eccrine and apocrine (arrows) sweat glands show
strong desmosomal labeling with PKP 3-speciﬁc antibodies. (c) Reaction of PKP 3-speciﬁc antibodies on liver is restricted to bile ductules
(arrow; see description of liver tissue in the legend to Figure 3) while hepatocytes are completely negative for PKP 3. The insert presents a
magniﬁcation of a bile ductule of human liver stained with antibodies against PKP 3, exhibiting a labeling of the desmosomal junctions. (d)
Bile ducts (here in a large portal ﬁeld) show a clear desmosomal reaction at the apical pole of cells (arrow). Scale bars: 100μm (d), 200μma ,
b, c.
2.3. Plakophilin 3. PKP 3 has a calculated mass of 87,081Da
andisdetectedwithanapparentmolecularweightofapprox-
imately 87kDa on Western blot analysis [57, 58]. Strikingly,
in contrast to the other PKP gens, PKP3 gene seems not
to encode for diﬀerent splice variants. PKP 3 is present
in the desmosomes of all cell layers of stratiﬁed epithelia
and in almost all simple epithelia, with the exception of
hepatocytes (Figure 4). In epidermal cells, PKP 3 is expressed
in a homogeneous pattern. Furthermore, it is detectable in
the desmosomes of some nonepithelial cells with the notable
exceptionofcardiomyocytes.Thisfactmayexplainthesevere
heart phenotype of PKP 2 loss, since PKP 2 is the only
PKP expressed in cardiomyocytes and its loss of function
cannot be compensated by the other PKPs. Although PKP
3 is mainly located in desmosomes, a signiﬁcant proportion
of the protein remains soluble in the cytoplasm. In contrast
to the other PKPs, PKP 3 has not been detected in the
nucleus.
A better understanding of the functions of PKP 3
came from the analyses of PKP 3 knockout mice [59].
In contrast to the other two PKPs, the PKP 3 knockout
phenotype is fairly mild. PKP 3-null animals are viable
and exhibit defects in the morphogenesis and morphology
of speciﬁc hair follicles. Moreover, alterations in density
and spacing of desmosomes and adherens junctions in
PKP 3-null epidermis and oral cavity were observed (own
unpublished observations). Consequently, PKP 3 is involved
in the development or maintenance of skin appendages.
Other PKP 3-positive epithelia appear normal in PKP 3-
null animals. In addition, an upregulation of the expression
of speciﬁc junctional proteins, such as the other PKPs, was
noticed. In comparison to the other two PKPs, the PKP
3 knockout phenotype is modest, which may in part be
due to the fact that an additional PKP is coexpressed in
most epithelia and may compensate for at least some of
the PKP 3 functions. Diseases in associated with the loss or
heterozygosity of PKP 3 have not been reported so far.
Surprisingly, among the three plakophilins, PKP 3
exhibits the most extensive binding repertoire to other
desmosomal components [60] and it demonstrates in silico
the most extensive interaction rate of desmosomal proteins,
as predicted for keratinocytes by Cirillo and Prime [61]. It is
capable to bind to most of the desmosomal proteins such as
all DSG and DSC isoforms, JUP and DSP and furthermore,
it is the only PKP that interacts with the smaller DSC-b
isoforms that are missing the binding site for plakoglobin
[60]. This implicates an apparent binding site for PKP 3
at the juxtamembrane domain of desmosomal cadherins.8 Dermatology Research and Practice
Both the PKP 3 head domain and the arm-repeats seem to be
crucial for these interactions, since most of the interactions
to other desmosomal proteins occur in yeast two-hybrid
assayonlyusingtheentirePKP3butnotusingtheindividual
domains [60].
FurtherPKP3interactionpartnersareemerging,thatare
not linked to cell adhesion, suggesting a broader biological
role of PKP 3. PKP 3 has been shown, for example, to
interact with RNA-binding proteins such as poly-A binding
protein C1 (PABPC1), FXR1 (Fragile X mental redartation-
1), and G3BP (GAP SH3 domain-binding protein) in stress
granules [62]. Stress granules develop when cells respond to
diverse environmental stress conditions and these particles
represent stalled translational complexes (for a recent review
of stress granules see [63]). The function of PKP 3 in stress
granules and the basis for the integration into stress granules
remain unclear, but it seems likely that this is not a general
function of all PKPs, since in addition to PKP 3, only PKP
1 but not PKP 2 has the ability to integrate into the stress
granules.
Another PKP 3-binding protein identiﬁed is dynamin-
like protein DNM-1L [64]. DNM-1L is involved in the
peroxisomal and mitochondrial ﬁssion and fusion as well
as mitochondrial-dependent apoptosis of cells [65, 66].
Althoughthebiologicalsigniﬁcanceforthisinteractionisnot
clear, it is tempting to speculate that the PKP 3 could aﬀect
the apoptotic response of cells.
2.4. Plakophilins in Tumors. Cellular adhesion molecules,
especially components of the adherens junctions such as E-
cadherin and β-catenin, have been shown to be important
in the development, progression, and metastasis of tumors
[67]. Likewise, several desmosomal proteins have also been
linked to malignant processes (reviewed in [68]). Reliable
data demonstrating a causal link between plakophilins and
tumor development are still forthcoming. Thus far, most
published studies focused on the expression of PKPs in
tumors and a correlation of PKP expression and tumor
prognosis. Well and moderately diﬀerentiated squamous
cell carcinomas (SqCC) of skin express PKP 1, whereas in
poorly diﬀerentiated tumors, PKP 1 is downregulated [69].
Tumor cells of basal cell carcinomas (BCC) exhibit a more
heterogeneous expression of PKP 1, being conﬁned to small
patchy areas [69]. In solid nodular BCCs, PKP 1 expression
has been found to be reduced in comparison to normal
overlaying epidermis and was hardly detectable in nodules
growing close to the basal epidermis. Immunohistochemical
analysis of the expression of PKP 1 in oral SqCCs revealed
similar results to those obtained with skin tumors [18, 70].
This is, however, conﬂicting with observations made by
others [71], who found that PKP 1 is strongly expressed
only in a small proportion of well-diﬀerentiated SqCCs.
Furthermore, these authors found that most of the well-
diﬀerentiated tumors are negative for PKP 1. Interestingly,
using cells derived from oral SqCCs, Sobolik-Delmaire et
al. [70] could demonstrate that cell lines expressing low
levels of PKP 1 exhibit increased cell mobility which is
reduced by ectopic expression of PKP 1. In contrast, another
cell line of an oral SqCC that expresses comparably high
levels of PKP 1 becomes more mobile and invasive in
vitro when PKP 1 is diminished by a shRNA knock-down
approach.
Interestingly, in a part of oral and pharyngeal SqCCs
analyzed by Schwarz et al. [18], nuclear localization of PKP 1
in tumor cells was noticed. This is remarkable since adjacent
non-neoplastic squamous epithelium did not show nuclear
PKP 1. In contrast to PKP 1, immunostaining for PKP 2 in
histological sections of SqCC is low and often restricted to
p e r i p h e r a l l yl o c a t e dt u m o rc e l l so ri se v e nc o m p l e t e l ya b s e n t
[18], whereas PKP 3 expression patterns are similar to PKP 1
inSqCC.TheexpressionofPKP3seemstocorrelateinversely
with the degree of malignancy of tumors.
An analysis of adenocarcinomas from diﬀerent organs
such as colon and pancreas revealed that PKP 1 is not
detected whereas PKP 2 and PKP 3 are frequently expressed
[18, 72], sometimes associated with a change from an apical
desmosomal staining to a staining of almost complete lateral
surface. The only exceptions were prostate adenocarcinomas
which displayed a low level of PKP 1 immunoreactivity.
Interestingly, in non-small cell lung carcinomas (NSCLC;
adenocarcinomas and SqCC) and cultured cells derived
thereof, Furukawa et al. observed an elevated expression
of PKP 3 [64]. Inhibition of PKP 3 expression by siRNA
a p p r o a c hi nN S C L Cc u l t u r e dc e l l sl e dt or e d u c e dc o l o n yf o r -
mation and less viability of cells. Moreover, over-expression
of PKP 3 in COS-cells caused enhanced proliferation rate
and elevated activity in in vitro invasion assay. The authors
postulated that PKP 3 may have an oncogenic function
when localized in the cytoplasm under certain conditions.
It thus appears that PKP 3 can potentially both, advance
tumorigenesis (as seen in some NSCLC) or suppress it (as
noticed for some SqCCs). Recent observations suggest that
PKP 3 may be involved in epithelial-mesenchymal transition
(EMT) that is of relevance especially for metastasis of tumor
cells [73]. Analysis of PKP 3 expression in invasive cancer
cells revealed that PKP 3 expression seems to be repressed
by the transcription factor ZEB 1, a potent repressor of E-
cadherin expression that is also involved in EMT, at least
in breast cancer cells. Nuclear accumulation of ZEB 1 (i.e.,
Zinc ﬁnger E-box-binding homeobox-1) correlated with a
loss of membrane staining for PKP 3. Similar observations
have been reported for PKP 2-repression by ZEB 2 in colon
cancer cells [74]. In conclusion, the precise role of PKPs in
tumor development and tumor progression is not clear. It
is possible that some of these proteins can function both,
as oncogenes or as tumor suppressors, depending on the
cell type studied. Further research is needed to establish a
causal link between PKP expression (or loss of expression)
and cancer.
In summary, in the past few years PKPs have been
recognized to be essential for desmosomal adhesion and
tissue integrity. Nevertheless, recent data suggest that PKPs
exert cellular functions unrelated to cell adhesion. Further
questions like the ability of individual PKPs to compensate
for the loss of one isoform and the role of PKPs in cell
signaling and in tumor development need to be further
investigated.Dermatology Research and Practice 9
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